All Stories

  1. Elgar Concise Encyclopedia of Food Law
  2. Patent law and food innovation
  3. Health and Health-Related Connected Objects: Regulatory Intersections, Grey Zones and Blind Spots
  4. 8 Exceptions and limitations (27 UPCA)
  5. Governing, Protecting, and Regulating the Future of Genome Editing
  6. Balancing Innovation, ‘Ordre Public’ and Morality in Human Germline Editing: A Call for More Nuanced Approaches in Patent Law
  7. Introduction: The Significance of ELSPI Perspectives in Governing, Protecting, and Regulating the Future of Genome Editing
  8. Balancing Innovation, ‘Ordre Public’ and Morality in Human Germline Editing: A Call for More Nuanced Approaches in Patent Law
  9. Governing, Protecting, and Regulating the Future of Genome Editing: The Significance of ELSPI Perspectives
  10. Sweden: Legal Response to Covid-19
  11. Biobank and Biomedical Research: Responsibilities of Controllers and Processors Under the EU General Data Protection Regulation
  12. Implementation of the Trade Secrets Directive into national law: Portugal and Spain
  13. Rules and Tools in the Battle Against Superbugs—A Call for Integrated Strategies and Enhanced International Collaboration to Promote Antimicrobial Drug Development
  14. Regulating germline editing in assisted reproductive technology: An EU cross‐disciplinary perspective
  15. Legal method and interpretation in international IP law: pluralism or systemic coherence
  16. Large expert-curated database for benchmarking document
  17. Patentability of human enhancement: from ethical dilemmas to legal (un)certainty
  18. Cutting edges and weaving threads in the gene editing (Я)evolution: reconciling scientific progress with legal, ethical, and social concerns
  19. A “Ray of Hope” for European Stem Cell Patents or “Out of the Smog into the Fog”? An Analysis of Recent European Case Law and How it Compares to the US
  20. The Impact of “Broccoli II” and “Tomatoes II” on European Patents in Conventional Breeding, GMOs, and Synthetic Biology: The Grand Finale of a Juicy Patents Tale?
  21. Patentability of methods of human enhancement